FDA Approves Less Expensive Insulin Glargine: By Kristin J. Kelley Edited by André Sofair, MD, MPH, and William E. Chavey,
FDA Approves Less Expensive Insulin Glargine: By Kristin J. Kelley
Edited by André Sofair, MD, MPH, and William E. Chavey, MD, MS
The FDA has approved an insulin glargine injection (marketed as Basaglar) for treating type 1 (adult and pediatric patients) and … NEJM Journal Watch.
Source: jwatch.org
RSS feed